Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 3 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 36 Breast Neoplasms 32 Rectal Neoplasms 25 Esophageal Neoplasms 21 Uterine Cervical Neoplasms 20 Head and Neck Neoplasms 20 Central Nervous System Neoplasms 19 Lung Neoplasms 18 Prostatic Neoplasms 17 Lymphoma 17 Esophageal Squamous Cell Carcinoma 17 Leukemia 16 Glioblastoma 16 Squamous Cell Carcinoma of Head and Neck 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Carcinoma, Hepatocellular 12 Sarcoma 10 Neuroblastoma 10 Neoplasms 10 Nasopharyngeal Carcinoma 10 Brain Neoplasms 10 Astrocytoma 10 Colorectal Neoplasms 9 Pancreatic Neoplasms 7 Glioma 7 Neoplasm Metastasis 6 Nasopharyngeal Neoplasms 6 Lymphoma, Non-Hodgkin 6 Stomach Neoplasms 5 Recurrence 5

Interventions

Temozolomide 2 nimotuzumab 1 Vinorelbine 1 Valproic Acid 1 Radiotherapy 1 Everolimus 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Diffuse Intrinsic Pontine Glioma × Radiotherapy × Clear all

NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡